EZR and osteosarcoma: We hypothesized that adenovirus-mediated siRNA targetting ezrin may inhibit the proliferation, metastasis, and invasion and promote apoptosis of osteosarcoma MG-63 cells, with hope to be helpful for future treatment of osteosarcoma.